Meta Growth Announces Opening of New Cannabis Retail Store in Downtown Toronto

TORONTO, Oct. 19, 2020 /CNW/ – Meta Growth Corp. (TSXV: META) (“Meta Growth”, “META” or the “Company”), a leading Canadian recreational cannabis retailer, today announced the opening of a new Meta Cannabis Co. cannabis retail store located at 79 Front Street East in the thriving area close to St. Lawrence Market in Toronto, Ontario. The store is META’s third open and operating store in Ontario. TheContinue reading “Meta Growth Announces Opening of New Cannabis Retail Store in Downtown Toronto”

Khiron Expands Medical Cannabis E-Learning Platform to UK Market

UK doctors to receive medical cannabis education through Khiron partnership with Medical Cannabis Clinicians Society (“MCCS”), effective Q3 2020 Expands reach of Khiron’s globally recognized cloud-based learning platform currently active in universities and institutions in Latin America MCCS is an independent, clinician-led organization sharing guidance to lead the medical cannabis conversation in the UK Program comprisesContinue reading “Khiron Expands Medical Cannabis E-Learning Platform to UK Market”

Halo Announces Closing of Acquisition of Outer Galactic Chocolates, a Type N License Holder in California. Plans California Edibles Launch by September.

All figures in USD unless stated otherwise –Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to its press release dated January 15, 2020, it has closed its acquisition of Outer Galactic Chocolates, LLC (“OGC”), holder of a Type N manufacturing license in Mendocino County.Continue reading “Halo Announces Closing of Acquisition of Outer Galactic Chocolates, a Type N License Holder in California. Plans California Edibles Launch by September.”

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Company surpasses 1,000 medical cannabis patient prescriptions in Colombia in the first 10 weeks of sales activity, representing a milestone towards meeting patient needs in Latin America and globally Company prudently managing financial resources through reduced expenses and held approximately $20 Million in cash at the end of June 2020, after closing Q1 with $24 Million and Q4 2019 with $36 Million Received authorization forContinue reading “Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone”

Innovative Industrial Properties Acquires Properties in New Jersey and Enters Into Long-Term Leases with Columbia Care

–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that it closed on sale-leaseback transactions with subsidiaries of Columbia Care Inc. (Columbia Care) for two properties in New Jersey, an industrial building comprising approximately 50,000Continue reading “Innovative Industrial Properties Acquires Properties in New Jersey and Enters Into Long-Term Leases with Columbia Care”

MedMen Announces Changes to Its Board of Directors and Resolution of MMMG-MC Litigation – Designated News Release

–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced that Adam Bierman, Co-Founder, stepped down as a member of the Company’s Board of Directors. In addition, Andrew Modlin, the Company’s other Co-Founder, stepped down as an observer to the Company’s Board of Directors. Mr. Modlin’s employment agreement with the Company expiredContinue reading “MedMen Announces Changes to Its Board of Directors and Resolution of MMMG-MC Litigation – Designated News Release”

FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

TORONTO, June 3, 2020 /CNW/ – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA)  to treat COVID-19, the disease caused by the SARS-CoV-2 virus.Continue reading “FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis”

Ayr Strategies to Hold First Quarter 2020 Conference Call on Thursday, May 21, 2020 at 8:30 a.m. ET

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Vertically-integrated cannabis multi-state operator (MSO), Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr”), will hold a conference call on Thursday, May 21, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2020. The Company will provide its financial results inContinue reading “Ayr Strategies to Hold First Quarter 2020 Conference Call on Thursday, May 21, 2020 at 8:30 a.m. ET”